eutrophil Inhibition during RSV bronchiolitis and other respiratory tract infections - Neon study

niversitair Medisch Centrum Utrecht0 个研究点目标入组 59 人开始时间: 待定最近更新: 2024年2月28日

适应症

试验速览

暂无简介。

•Group 1: RSV, mechanical ventilation (n<=35):
•Age < 25 months
•Respiratory insufficiency requiring mechanical ventilation due to proven RSV LRTI ;Group 2: RSV, no ventilation (n<=35):
•Age < 25 months
•Hospitalization for proven RSV LRTI (positive PCR or DIFF);Group 3: Non-ventilated hospitalized controls (n<=35):
•Age < 25 months
•No fever or other signs of infection, no respiratory symptoms, ;Group 4a: Ventilated controls without infection (n<=35)
•Age < 25 months
•Mechanical ventilation for non-infectious indication (e.g. status epilepticus, trauma);Group 4b: Ventilated controls with infection (n<=35)
•Age < 25 months
•Mechanical ventilation for non-RSV LRTI (e.g. bacterial pneumonia, sepsis)

•Severe comorbidity, such as any organ dysfunction except for cardiac malformalities or the presence of a trachea canulue.
•Immune suppressed patients such as patient using immune suppressives or receiving chemotherapy.
•Any severe congenital or acquired abnormality, such as Down syndrome

发起方

niversitair Medisch Centrum Utrecht